Abstract

Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) has been shown to act as a signaling molecule that is involved in many cellular functions. This study investigated the effect of H<sub>2</sub>O<sub>2</sub> on the [<sup>3</sup>H]-2-deoxyglucose (2-DG) uptake and its related signaling pathways in mouse embryonic stem (ES) cells. H<sub>2</sub>O<sub>2</sub> significantly increased the level of 2-DG uptake in a time- (> 4 hr) and concentration- (>10<sup>-4</sup> M) dependent manner due to an increase in V<sub>max</sub> but not K<sub>m</sub>. Indeed, H<sub>2</sub>O<sub>2</sub> increased the mRNA and protein level of glucose transporter 1 (GLUT 1). PD 98059 (a p44/42 MAPKs inhibitor, 10<sup>-5</sup> M), SB 203580 (a p38 MAPK inhibitor, 10<sup>-6</sup> M), and SP 600125 (a SAPK/JNK inhibitor, 10<sup>-6</sup> M) blocked the H<sub>2</sub>O<sub>2</sub>-induced increase in 2-DG uptake. H<sub>2</sub>O<sub>2</sub> also increased phosphorylation of p44/42 mitogen activated protein kinases (MAPKs), p38 MAPK, and stress-activated protein kinase/Jun-N-terminal kinase (SAPK/JNK). In addition, H<sub>2</sub>O<sub>2</sub> stimulated the translocation of cytosolic phospholipase A<sub>2</sub> (cPLA<sub>2</sub>) from the cytosolic fraction to the membrane fraction, the release of arachidonic acid, and the activation of NF-κB. AACOCF<sub>3</sub> or mepacrine (cPLA<sub>2</sub> inhibitors, 10<sup>-6</sup> M), SN 50 (NF-κB nucleus translocation inhibitor, 500 ng/ml) or Bay11-7082 (a IκB-α phosphorylation inhibitor, 2x10<sup>-5</sup> M) blocked the H<sub>2</sub>O<sub>2</sub>-induced increase in 2-DG uptake. H<sub>2</sub>O<sub>2</sub> increased the protein level of glucose transporter 1 (GLUT 1), which was blocked by PD 98059, SB 203580, SP 600125, mepacrine, or Bay11-7082. In conclusion, H<sub>2</sub>O<sub>2</sub> increases the 2-DG uptake via MAPKs, cPLA<sub>2</sub>, and NF-κB signaling pathways in mouse ES cells.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.